Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4918-4925

  Ritprajak, Patcharee ^a,b   Hashiguchi, Masaaki ^a   Tsushima, Fumihiko ^a   Chalermsarp, Narumon ^a,c   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; GAMMA INTERFERON; HAPTEN; PROGRAMMED DEATH 1 LIGAND 1; APOPTOSIS REGULATORY PROTEIN; AUTACOID; B7 ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PDCD1 PROTEIN, HUMAN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOREGULATION; KERATINOCYTE; LYMPH NODE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN SENSITIZATION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CONTACT DERMATITIS; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DERMATITIS, CONTACT; DOWN-REGULATION; HUMANS; INFLAMMATION MEDIATORS; JURKAT CELLS; KERATIN-14; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; PROMOTER REGIONS, GENETIC; SKIN;

EID: 77954477938     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902478     Document Type: Article

References (47)

1. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225-252.
2. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
3. Vincenti, F., and M. Luggen. 2007. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu. Rev. Med. 58: 347-358.
4. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
5. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
6. Koga, N., J. Suzuki, H. Kosuge, G. Haraguchi, Y. Onai, H. Futamatsu, Y. Maejima, R. Gotoh, H. Saiki, F. Tsushima, et al. 2004. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler. Thromb. Vasc. Biol. 24: 2057-2062.
7. Hori, J., M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma. 2006. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177: 5928-5935.
8. Shen, L., Y. Jin, G. J. Freeman, A. H. Sharpe, and M. R. Dana. 2007. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J. Immunol. 179: 3672-3679.
9. + T lymphocytes. Immunity 20: 327-336.
10. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
11. + T cell tolerance. Hepatology 47: 296-305.
12. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H. Sayegh, and J. A. Bluestone. 2006. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203: 2737-2747.
13. + T cell tolerance to tissue antigens. J. Immunol. 177: 8291-8295.
14. Tanaka, K., M. J. Albin, X. Yuan, K. Yamaura, A. Habicht, T. Murayama, M. Grimm, A. M. Waaga, T. Ueno, R. F. Padera, et al. 2007. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J. Immunol. 179: 5204-5210.
15. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700.
16. Wang, C. J., F. C. Chou, C. H. Chu, J. C. Wu, S. H. Lin, D. M. Chang, and H. K. Sytwu. 2008. Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models. Diabetes 57: 1861-1869.
17. Dutz, J. P. 2009. T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. J. Invest. Dermatol. 129: 309-314.
18. Lefrançois, L., and L. Puddington. 2006. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu. Rev. Immunol. 24: 681-704.
19. Iwasaki, A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25: 381-418.
20. Nestle, F. O., P. Di Meglio, J. Z. Qin, and B. J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9: 679-691.
21. + keratinocytes. J. Immunol. 147: 4155-4161.
22. Nickoloff, B. J., and L. A. Turka. 1994. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today 15: 464-469.
23. + T cells. Eur. J. Immunol. 37: 1485-1493.
24. Youngnak-Piboonratanakit, P., F. Tsushima, N. Otsuki, H. Igarashi, U. Machida, H. Iwai, Y. Takahashi, K. Omura, H. Yokozeki, and M. Azuma. 2004. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol. Lett. 94: 215-222.
25. Tsushima, F., H. Iwai, N. Otsuki, M. Abe, S. Hirose, T. Yamazaki, H. Akiba, H. Yagita, Y. Takahashi, K. Omura, et al. 2003. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33: 2773-2782.
26. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546.
27. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony- stimulating factor. J. Exp. Med. 176: 1693-1702.
28. Kamimura, Y., H. Iwai, J. Piao, M. Hashiguchi, and M. Azuma. 2009. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. J. Immunol. 182: 2708-2716.
29. Ritprajak, P., M. Hashiguchi, and M. Azuma. 2008. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol. Ther. 16: 1323-1330.
30. + T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases. J. Immunol. 167: 4981-4986.
31. Chalermsarp, N., and M. Azuma. 2009. Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes. Immunology 127: 558-566.
32. Kish, D. D., X. Li, and R. L. Fairchild. 2009. CD8 T cells producing IL-17 and IFN-γ initiate the innate immune response required for responses to antigen skin challenge. J. Immunol. 182: 5949-5959.
33. + T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168: 3079-3087.
34. Enk, A. H., and S. I. Katz. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89: 1398-1402.
35. Ishida, Y., Y. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11: 3887-3895.
36. Creusot, R. J., S. S. Yaghoubi, P. Chang, J. Chia, C. H. Contag, S. S. Gambhir, and C. G. Fathman. 2009. Lymphoid-tissue-specific homing of bone-marrowderived dendritic cells. Blood 113: 6638-6647.
37. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
38. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
39. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227.
40. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
41. Haspot, F., T. Fehr, C. Gibbons, G. Zhao, T. Hogan, T. Honjo, G. J. Freeman, and M. Sykes. 2008. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood 112: 2149-2155.
42. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
43. Iwai, Y., M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato. 2002. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 99: 12293-12297.
44. Curiel, T. J., S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. L. Knutson, B. Daniel, M. C. Zimmermann, et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9: 562-567.
45. Grabbe, S., K. Steinbrink, M. Steinert, T. A. Luger, and T. Schwarz. 1995. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155: 4207-4217.
46. Nickoloff, B. J., R. S. Mitra, J. Green, X. G. Zheng, Y. Shimizu, C. Thompson, and L. A. Turka. 1993. Accessory cell function of keratinocytes for superantigens: dependence on lymphocyte function-associated antigen-1/ intercellular adhesion molecule-1 interaction. J. Immunol. 150: 2148-2159.
47. Goodman, R. E., F. Nestle, Y. M. Naidu, J. M. Green, C. B. Thompson, B. J. Nickoloff, and L. A. Turka. 1994. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-γ. J. Immunol. 152: 5189-5198.